AAV-mediated delivery of Cas13d–CAGEX to the striatum of premanifest zQ175/+ HD mice resulted in allele-selective suppression of mHTT mRNA and protein aggregates while maintaining normal HTT mRNA and protein levels, significantly improved motor function and attenuated striatal atrophy (Morelli et al., 2023). This evidence concerns the gene HTT and Huntington disease.